Blagden, S. P., Molife, L. R., Seebaran, A., Payne, M., Reid, A. H. M., Protheroe, A. S., . . . Middleton, M. R. (2008). A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours. Nature Publishing Group.
Citación estilo ChicagoBlagden, S P., et al. A Phase I Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, With Docetaxel in Patients With Advanced Solid Tumours. Nature Publishing Group, 2008.
Cita MLABlagden, S P., et al. A Phase I Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, With Docetaxel in Patients With Advanced Solid Tumours. Nature Publishing Group, 2008.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.